Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.51 | N/A |
| PEG Ratio (TTM) | -0.73 | N/A |
| P/S Ratio (TTM) | 1.39 | N/A |
| P/B Ratio (TTM) | 0.86 | N/A |
| P/FCF Ratio (TTM) | -2.31 | N/A |
| Price to 5YR AVG Earnings Ratio | 5.49 | N/A |
| Price to 5YR AVG FCF Ratio | -1.38 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.62% | N/A |
| ROE (TTM) | 16.55% | N/A |
| Net Profit Margin (TTM) | 25.20% | N/A |
| ROIC 5YR AVG | 16.85% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -6.58% | 58.68% | 39.21% |
| Revenue | 19.01% | 51.55% | 35.24% |
| Net Income | -6.15% | 60.75% | 41.22% |
| Cash Flow | -216.80% | -197.55% | 270.69% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 34.19 | N/A |
| Quick Ratio (TTM) | 34.19 | N/A |
| D/E Ratio (TTM) | 1.84 | N/A |
| Interest Coverage (TTM) | 1.45 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 1.03 | N/A |
| LTL to 5YR AVG FCF | -0.48 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.09% | N/A |